207 related articles for article (PubMed ID: 31342369)
1. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers.
Kantor O; Chang C; Bleicher RJ; Moran M; Connolly JL; Kurtzman SH; Yao K;
Ann Surg Oncol; 2019 Oct; 26(10):3080-3088. PubMed ID: 31342369
[TBL] [Abstract][Full Text] [Related]
2. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.
Yao K; Bleicher R; Moran M; Chang C; Dietz J; Stearns V; Connolly J; Sarantou T; Kurtzman S;
Cancer Med; 2020 May; 9(9):3088-3096. PubMed ID: 32159280
[TBL] [Abstract][Full Text] [Related]
3. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
[TBL] [Abstract][Full Text] [Related]
4. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
5. Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?
Taylor MA; Allen CM; Presson AP; Millar MM; Zurbuchen R; Matsen CB
Ann Surg Oncol; 2019 Oct; 26(10):3224-3231. PubMed ID: 31342374
[TBL] [Abstract][Full Text] [Related]
6. Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.
Musiello T; Bornhammar E; Saunders C
ANZ J Surg; 2013 Jul; 83(7-8):527-32. PubMed ID: 23043449
[TBL] [Abstract][Full Text] [Related]
7. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.
Portschy PR; Abbott AM; Burke EE; Nzara R; Marmor S; Kuntz KM; Tuttle TM
Ann Surg Oncol; 2015 Nov; 22(12):3846-52. PubMed ID: 25762480
[TBL] [Abstract][Full Text] [Related]
9. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Rosenberg SM; Tracy MS; Meyer ME; Sepucha K; Gelber S; Hirshfield-Bartek J; Troyan S; Morrow M; Schapira L; Come SE; Winer EP; Partridge AH
Ann Intern Med; 2013 Sep; 159(6):373-81. PubMed ID: 24042365
[TBL] [Abstract][Full Text] [Related]
10. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.
Bellavance E; Peppercorn J; Kronsberg S; Greenup R; Keune J; Lynch J; Collyar D; Magder L; Tilburt J; Hlubocky F; Yao K
Ann Surg Oncol; 2016 Sep; 23(9):2779-87. PubMed ID: 27169770
[TBL] [Abstract][Full Text] [Related]
11. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
[TBL] [Abstract][Full Text] [Related]
12. Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.
Wang F; Amara D; Peled AW; Sbitany H; Foster RD; Ewing CA; Alvarado M; Esserman LJ
Ann Surg Oncol; 2015 Oct; 22(10):3338-45. PubMed ID: 26215194
[TBL] [Abstract][Full Text] [Related]
13. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
15. Topical estrogen prescribing patterns for urogenital atrophy among women with breast cancer: results of a national provider survey.
Richter LA; Han J; Bradley S; Lynce FC; Willey SC; Tefera E; Pollack CE
Menopause; 2019 Jul; 26(7):714-719. PubMed ID: 30939535
[TBL] [Abstract][Full Text] [Related]
16. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
18. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
19. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
20. The attitude and perception of breast reconstruction by general surgeons in Saudi Arabia.
Awan BA; Samargandi OA; Aldaqal SM; Alharbi AM; Alghaithi Z
Ann Saudi Med; 2013; 33(6):559-65. PubMed ID: 24413859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
